C. Russell Trenary III
Overview
C. Russell Trenary III received an average of $4M in total compensation, including $448K in salary, at Outlook Therapeutics from 2021 to 2023.
Source: SEC filings on February 8, 2024, February 15, 2023, and January 27, 2022.
Related executives
We found seven more executives who work or worked at Outlook Therapeutics.
Terry Dagnon
Outlook Therapeutics
Former Chief Operations Officer
Jeff Evanson
Outlook Therapeutics
Chief Commercial Officer
Lawrence Kenyon
Outlook Therapeutics
Chief Financial Officer
Pankaj Mohan
Outlook Therapeutics
Chief Executive Officer
Kenneth Bahrt
Outlook Therapeutics
Chief Medical Officer
Stephen McAndrew
Outlook Therapeutics
Former Senior Vice President, Business Strategy & Development
Kogan Bao
Outlook Therapeutics